Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients.
about
Clinical Experience with the Integrase Inhibitors Dolutegravir and Elvitegravir in HIV-infected Patients: Efficacy, Safety and Tolerance.Effectiveness, Safety, and Costs of a Treatment Switch to Dolutegravir Plus Rilpivirine Dual Therapy in Treatment-Experienced HIV Patients.Reply to Letter 'Morning dosing for dolutegravir-related insomnia and sleep disorders' by Capetti et al.Severe depression as a neuropsychiatric side effect induced by dolutegravir.
P2860
Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Efficacy and tolerability of d ...... logically suppressed patients.
@en
type
label
Efficacy and tolerability of d ...... logically suppressed patients.
@en
prefLabel
Efficacy and tolerability of d ...... logically suppressed patients.
@en
P2093
P50
P1433
P1476
Efficacy and tolerability of d ...... logically suppressed patients.
@en
P2093
Alberto Borghetti
Alessandra Latini
Amedeo Capetti
Andrea Giacometti
Chiara Picarelli
Filippo Lagi
Gaetana Sterrantino
Giordano Madeddu
Maria V Cossu
Odoacre Study Group
P304
P356
10.1097/QAD.0000000000001357
P407
P577
2017-01-01T00:00:00Z